DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Biogeneration III Services B.V.
Biogeneration III Services B.V.
Shaping new life-science ventures.
venture manager, reported GAV $155M across 5 vehicles
Importance
37
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
13
low
Identity and regulatory footprint
- Headquarters
- Naarden, Netherlandsadviserinfo.sec.gov
- Office address
- GOOIMEER 2-35, Naarden, 1411 DCadviserinfo.sec.gov
- Business phone
- 31356993000adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 28, 2024
- Private funds reported
- 5 (5 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $155Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Biogeneration Group Holding B.V. (Shareholder), E
- business phone
- 31356993000adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
41 observed deals
Stated (the firm’s website)
- Sectors
- biotech, climate, media
- Stages
- seed, early
- Geography
- europe
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 41
Funds and vehicles
5 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Biogeneration Capital Fund III C.V. | Fund | unknown | Unknown | $83.2M Mar 28, 2024 | 36 | unknown | unknown |
| Biogeneration Capital Fund IV C.V. | Fund | unknown | Unknown | $58.1M Mar 28, 2024 | 43 | unknown | unknown |
| Biogeneration III Co-Investment Fund C.V. | SPV or co-invest vehicle | unknown | Unknown | $6.6M Mar 28, 2024 | 1 | unknown | unknown |
| Fonds Investeringsrijpe Starters (first) Cooperatief U.A. | Fund | unknown | Unknown | $3.7M Mar 28, 2024 | 2 | unknown | unknown |
| Biogeneration Capital Fund V | Fund | unknown | Unknown | $3.3M Mar 28, 2024 | 33 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
20 current, 1 departed
Andree Blaukat
Board or advisorySenior Advisor
Arnon Kater
Board or advisorySenior Advisor
Roger Ulrich
Board or advisorySenior Advisor
Daniela Couto
General partnerGeneral Partner
Keno Gutierrez
General partnerGeneral Partner
Edward van Wezel
Managing partnerManaging Partner
Oskar Slotboom
Managing partnerManaging Partner
Case Studies
OtherPortfolio
Robbert van de Griendt
OtherHead of Investment Relations
Patricia Vonk
PartnerAML/KYC Manager
Claire van Viersen
Platform and operationsExecutive Assistant
Cyril Lesser
Platform and operationsVice President Finance | Funds
Laura Asbjornsen
Platform and operationsHead of Communications
Machteld Groeneveld
Platform and operationsChief Compliance Officer & Legal Affairs
Diede Brunen
PrincipalPrincipal
Alexander Vos
Venture partnerVenture Partner
Arnoud Dijkstra
Venture partnerVenture Partner
Elena Ritsou
Venture partnerVenture Partner
Rob de Ree
Venture partnerVenture Partner
Wouter Verhoeven
Venture partnerVenture Partner
1 departed (kept with end dates)
- Olga Ziessen · Executive Assistant · ? to Sep 16, 2026 Inference
Investments on record
41 edges, 41 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Sep 16, 2026SurgVision no longer listed on Biogeneration III Services B.V.'s portfolio pageRemoved from portfolio pagePortfolioInferenceSurgVisionVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Lanthio no longer listed on Biogeneration III Services B.V.'s portfolio pageRemoved from portfolio pagePortfolioInferenceLanthioVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026VectorY no longer listed on Biogeneration III Services B.V.'s portfolio pageRemoved from portfolio pagePortfolioInferenceVectorYVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Olga Ziessen (Executive Assistant) no longer on the team page of Biogeneration III Services B.V.Person leftPeopleInferenceOlga ZiessenVenture organization websites (about, team, portfolio, thesis, news pages)
- Jan 3, 2024Biogeneration Capital Fund IV C.V. first reported on Form ADV by Biogeneration III Services B.V. (Venture Capital Fund), GAV $65,000,000Fund first reported on Form ADVFundsFactBiogeneration Capital Fund IV C.V.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 3, 2024Biogeneration III Services B.V. first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 3, 2024Fonds Investeringsrijpe Starters (first) Cooperatief U.A. first reported on Form ADV by Biogeneration III Services B.V. (Venture Capital Fund), GAV $4,500,000Fund first reported on Form ADVFundsFactFonds Investeringsrijpe Starters (first) Cooperatief U.A.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 3, 2024Biogeneration Capital Fund V first reported on Form ADV by Biogeneration III Services B.V. (Venture Capital Fund), GAV $4,000,000Fund first reported on Form ADVFundsFactBiogeneration Capital Fund VSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 3, 2024Biogeneration Capital Fund III C.V. first reported on Form ADV by Biogeneration III Services B.V. (Venture Capital Fund), GAV $86,448,794Fund first reported on Form ADVFundsFactBiogeneration Capital Fund III C.V.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 3, 2024Biogeneration III Co-Investment Fund C.V. first reported on Form ADV by Biogeneration III Services B.V. (Venture Capital Fund), GAV $7,312,282Fund first reported on Form ADVFundsFactBiogeneration III Co-Investment Fund C.V.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $155M across 5 vehicles
Evidence
33 observations from 2 sources